Some months ago the Council on Pharmacy and Chemistry appointed a committee to investigate and to report on the abuses connected with the patenting and trade-marking of medicines. This committee presented a preliminary report on the general subject of patents,1 in which attention is directed to some of the complications that will be encountered in any attempt to equitably solve the patent and trade-mark problems as they present themselves at the present time. The committee has also submitted a second report,2 discussing the reasons why the widely used names for some of the newer remedies should be recognized as being public property and not in any sense proprietary. These two reports are of necessity purely preliminary and as yet no attempt has been made to generalize or to offer specific suggestions other than that the problems involved are well deserving of careful consideration on the part of physicians
WILBERT MI. PRESENT STATUS OF THE LAWS RELATING TO PATENTS AND TRADE-MARKS. JAMA. 1912;LIX(11):834–835. doi:10.1001/jama.1912.04270090078002
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: